Global and United States Ponatinib Market Report & Forecast 2024-2031

Report ID: 1840824 | Published Date: Sep 2024 | No. of Page: 79 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Ponatinib Product Introduction
    1.2 Global Ponatinib Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Ponatinib Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Ponatinib Sales in Volume for the Year 2017-2028
    1.3 United States Ponatinib Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Ponatinib Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Ponatinib Sales in Volume for the Year 2017-2028
    1.4 Ponatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Ponatinib in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Ponatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Ponatinib Market Dynamics
        1.5.1 Ponatinib Industry Trends
        1.5.2 Ponatinib Market Drivers
        1.5.3 Ponatinib Market Challenges
        1.5.4 Ponatinib Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Ponatinib Market Segment by Type
        2.1.1 45mg
        2.1.2 15mg
    2.2 Global Ponatinib Market Size by Type
        2.2.1 Global Ponatinib Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Ponatinib Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Ponatinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Ponatinib Market Size by Type
        2.3.1 United States Ponatinib Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Ponatinib Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Ponatinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Ponatinib Market Segment by Application
        3.1.1 CML
        3.1.2 ALL
    3.2 Global Ponatinib Market Size by Application
        3.2.1 Global Ponatinib Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Ponatinib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Ponatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Ponatinib Market Size by Application
        3.3.1 United States Ponatinib Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Ponatinib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Ponatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ponatinib Competitor Landscape by Company
    4.1 Global Ponatinib Market Size by Company
        4.1.1 Top Global Ponatinib Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Ponatinib Revenue by Manufacturer (2017-2022)
        4.1.3 Global Ponatinib Sales by Manufacturer (2017-2022)
        4.1.4 Global Ponatinib Price by Manufacturer (2017-2022)
    4.2 Global Ponatinib Concentration Ratio (CR)
        4.2.1 Ponatinib Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ponatinib in 2021
        4.2.3 Global Ponatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Ponatinib Manufacturing Base Distribution, Product Type
        4.3.1 Global Ponatinib Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Ponatinib Product Type
        4.3.3 Date of International Manufacturers Enter into Ponatinib Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Ponatinib Market Size by Company
        4.5.1 Top Ponatinib Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Ponatinib Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Ponatinib Sales by Players (2020, 2021 & 2022)
5 Global Ponatinib Market Size by Region
    5.1 Global Ponatinib Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Ponatinib Market Size in Volume by Region (2017-2028)
        5.2.1 Global Ponatinib Sales in Volume by Region: 2017-2022
        5.2.2 Global Ponatinib Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Ponatinib Market Size in Value by Region (2017-2028)
        5.3.1 Global Ponatinib Sales in Value by Region: 2017-2022
        5.3.2 Global Ponatinib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Ponatinib Market Size YoY Growth 2017-2028
        6.1.2 North America Ponatinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Ponatinib Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Ponatinib Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Ponatinib Market Size YoY Growth 2017-2028
        6.3.2 Europe Ponatinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Ponatinib Market Size YoY Growth 2017-2028
        6.4.2 Latin America Ponatinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Ponatinib Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Ponatinib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 ARIAD Pharmaceuticals
        7.1.1 ARIAD Pharmaceuticals Corporation Information
        7.1.2 ARIAD Pharmaceuticals Description and Business Overview
        7.1.3 ARIAD Pharmaceuticals Ponatinib Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 ARIAD Pharmaceuticals Ponatinib Products Offered
        7.1.5 ARIAD Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Ponatinib Industry Chain Analysis
    8.2 Ponatinib Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Ponatinib Distributors
    8.3 Ponatinib Production Mode & Process
    8.4 Ponatinib Sales and Marketing
        8.4.1 Ponatinib Sales Channels
        8.4.2 Ponatinib Distributors
    8.5 Ponatinib Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Ponatinib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Ponatinib Market Trends
    Table 3. Ponatinib Market Drivers
    Table 4. Ponatinib Market Challenges
    Table 5. Ponatinib Market Restraints
    Table 6. Global Ponatinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ponatinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ponatinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ponatinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ponatinib Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ponatinib Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Ponatinib Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Ponatinib Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Ponatinib Sales Share by Manufacturer, 2017-2022
    Table 15. Global Ponatinib Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Ponatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Ponatinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ponatinib as of 2021)
    Table 18. Top Players of Ponatinib in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Ponatinib Product Type
    Table 20. Date of International Manufacturers Enter into Ponatinib Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Ponatinib Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Ponatinib Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Ponatinib Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Ponatinib Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Ponatinib Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Ponatinib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Ponatinib Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Ponatinib Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Ponatinib Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Ponatinib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Ponatinib Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Ponatinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Ponatinib Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Ponatinib Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Ponatinib Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Ponatinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Ponatinib Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Ponatinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Ponatinib Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Ponatinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. ARIAD Pharmaceuticals Corporation Information
    Table 43. ARIAD Pharmaceuticals Description and Business Overview
    Table 44. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. ARIAD Pharmaceuticals Ponatinib Product
    Table 46. ARIAD Pharmaceuticals Recent Development
    Table 47. Key Raw Materials Lists
    Table 48. Raw Materials Key Suppliers Lists
    Table 49. Ponatinib Customers List
    Table 50. Ponatinib Distributors List
    Table 51. Research Programs/Design for This Report
    Table 52. Key Data Information from Secondary Sources
    Table 53. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ponatinib Product Picture
    Figure 2. Global Ponatinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ponatinib Market Size 2017-2028 (US$ Million)
    Figure 4. Global Ponatinib Sales 2017-2028 (K Units)
    Figure 5. United States Ponatinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Ponatinib Market Size 2017-2028 (US$ Million)
    Figure 7. United States Ponatinib Sales 2017-2028 (K Units)
    Figure 8. United States Ponatinib Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Ponatinib Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Ponatinib Report Years Considered
    Figure 11. Product Picture of 45mg
    Figure 12. Product Picture of 15mg
    Figure 13. Global Ponatinib Market Share by Type in 2022 & 2028
    Figure 14. Global Ponatinib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Ponatinib Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Ponatinib Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Ponatinib Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Ponatinib Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Ponatinib Market Share by Type in 2022 & 2028
    Figure 20. United States Ponatinib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Ponatinib Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Ponatinib Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Ponatinib Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Ponatinib Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of CML
    Figure 26. Product Picture of ALL
    Figure 27. Global Ponatinib Market Share by Application in 2022 & 2028
    Figure 28. Global Ponatinib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Ponatinib Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Ponatinib Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Ponatinib Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Ponatinib Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Ponatinib Market Share by Application in 2022 & 2028
    Figure 34. United States Ponatinib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Ponatinib Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Ponatinib Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Ponatinib Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Ponatinib Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Ponatinib Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Ponatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Ponatinib Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Ponatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Ponatinib Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Ponatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Ponatinib Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Ponatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Ponatinib Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Ponatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Ponatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Ponatinib Value Chain
    Figure 73. Ponatinib Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ARIAD Pharmaceuticals
Frequently Asked Questions
Ponatinib report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ponatinib report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ponatinib report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ponatinib Drugs

Ponatinib Drugs market is segmented by region (country), players, by Type and by Application. Pla ... Read More

Iclusig

Iclusig market is segmented by region (country), players, by Type and by Application. Players, st ... Read More